Cargando…

An automated controlled-release device for intravaginal hormone delivery

Our objective was to develop and validate an electronically controlled hormone-delivery device for reproductive control of cattle. After development and in vitro testing of a prototype device for intravaginal (IVG) hormone release, we aimed to demonstrate the feasibility of inducing luteal regressio...

Descripción completa

Detalles Bibliográficos
Autores principales: Masello, M., Ren, Y., Erickson, D., Giordano, J.O.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9623694/
https://www.ncbi.nlm.nih.gov/pubmed/36340429
http://dx.doi.org/10.3168/jdsc.2020-18816
_version_ 1784822060181094400
author Masello, M.
Ren, Y.
Erickson, D.
Giordano, J.O.
author_facet Masello, M.
Ren, Y.
Erickson, D.
Giordano, J.O.
author_sort Masello, M.
collection PubMed
description Our objective was to develop and validate an electronically controlled hormone-delivery device for reproductive control of cattle. After development and in vitro testing of a prototype device for intravaginal (IVG) hormone release, we aimed to demonstrate the feasibility of inducing luteal regression by automated treatment with PGF(2α). The IVG device comprises an outer 3D-printed plastic housing, fluid reservoirs connected to delivery pumps and tubing, a programmable circuit board, and a retention mechanism. For in vitro testing, 4 pumps were programmed to release different target volumes (0.1, 0.2, 0.5, 1.0, and 2.0 mL) in 4 replicates (n = 80). A Bland-Altman plot was constructed to assess the magnitude of disagreement between expected and delivered volumes. Observations fell within acceptable limits of agreement (1.96 standard deviations) >95% of the time, indicating overall good agreement (mean difference = −0.005 mL). To assess in vivo performance of the IVG device, lactating Holstein cows with at least 1 corpus luteum ≥15 mm in diameter were randomly allocated to 1 of 3 treatments: (1) IM-PGF (n = 6): two 25-mg intramuscular doses of PGF(2α) 24 h apart; (2) DEV-PGF (n = 6): four 25-mg doses of PGF(2α) released automatically by the IVG device at 10- or 12-h intervals; and (3) DEV-CTL (n = 4): insertion of an empty IVG device (placebo control). Blood samples were collected at 0, 12, 24, 36, 48, and 72 h after treatment. Data were analyzed by ANOVA with repeated measures. All devices (10/10) remained in situ until removed at 48 h. Progesterone (P4) concentrations from 0 to 72 h were affected by treatment, time, and their interaction. Concentrations of P4 did not differ at time 0 but differed from 24 to 72 h: cows in IM-PGF and DEV-PGF had lesser P4 than cows in DEV-CTL. Conversely, P4 did not differ for IM-PGF and DEV-PGF during the experiment. We conclude that the current IVG hormone-releasing device prototype can be programmed to automatically release PGF(2α) for successful induction of luteal regression in lactating dairy cows.
format Online
Article
Text
id pubmed-9623694
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-96236942022-11-04 An automated controlled-release device for intravaginal hormone delivery Masello, M. Ren, Y. Erickson, D. Giordano, J.O. JDS Commun Research Our objective was to develop and validate an electronically controlled hormone-delivery device for reproductive control of cattle. After development and in vitro testing of a prototype device for intravaginal (IVG) hormone release, we aimed to demonstrate the feasibility of inducing luteal regression by automated treatment with PGF(2α). The IVG device comprises an outer 3D-printed plastic housing, fluid reservoirs connected to delivery pumps and tubing, a programmable circuit board, and a retention mechanism. For in vitro testing, 4 pumps were programmed to release different target volumes (0.1, 0.2, 0.5, 1.0, and 2.0 mL) in 4 replicates (n = 80). A Bland-Altman plot was constructed to assess the magnitude of disagreement between expected and delivered volumes. Observations fell within acceptable limits of agreement (1.96 standard deviations) >95% of the time, indicating overall good agreement (mean difference = −0.005 mL). To assess in vivo performance of the IVG device, lactating Holstein cows with at least 1 corpus luteum ≥15 mm in diameter were randomly allocated to 1 of 3 treatments: (1) IM-PGF (n = 6): two 25-mg intramuscular doses of PGF(2α) 24 h apart; (2) DEV-PGF (n = 6): four 25-mg doses of PGF(2α) released automatically by the IVG device at 10- or 12-h intervals; and (3) DEV-CTL (n = 4): insertion of an empty IVG device (placebo control). Blood samples were collected at 0, 12, 24, 36, 48, and 72 h after treatment. Data were analyzed by ANOVA with repeated measures. All devices (10/10) remained in situ until removed at 48 h. Progesterone (P4) concentrations from 0 to 72 h were affected by treatment, time, and their interaction. Concentrations of P4 did not differ at time 0 but differed from 24 to 72 h: cows in IM-PGF and DEV-PGF had lesser P4 than cows in DEV-CTL. Conversely, P4 did not differ for IM-PGF and DEV-PGF during the experiment. We conclude that the current IVG hormone-releasing device prototype can be programmed to automatically release PGF(2α) for successful induction of luteal regression in lactating dairy cows. Elsevier 2020-09-02 /pmc/articles/PMC9623694/ /pubmed/36340429 http://dx.doi.org/10.3168/jdsc.2020-18816 Text en © 2020. https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Research
Masello, M.
Ren, Y.
Erickson, D.
Giordano, J.O.
An automated controlled-release device for intravaginal hormone delivery
title An automated controlled-release device for intravaginal hormone delivery
title_full An automated controlled-release device for intravaginal hormone delivery
title_fullStr An automated controlled-release device for intravaginal hormone delivery
title_full_unstemmed An automated controlled-release device for intravaginal hormone delivery
title_short An automated controlled-release device for intravaginal hormone delivery
title_sort automated controlled-release device for intravaginal hormone delivery
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9623694/
https://www.ncbi.nlm.nih.gov/pubmed/36340429
http://dx.doi.org/10.3168/jdsc.2020-18816
work_keys_str_mv AT masellom anautomatedcontrolledreleasedeviceforintravaginalhormonedelivery
AT reny anautomatedcontrolledreleasedeviceforintravaginalhormonedelivery
AT ericksond anautomatedcontrolledreleasedeviceforintravaginalhormonedelivery
AT giordanojo anautomatedcontrolledreleasedeviceforintravaginalhormonedelivery
AT masellom automatedcontrolledreleasedeviceforintravaginalhormonedelivery
AT reny automatedcontrolledreleasedeviceforintravaginalhormonedelivery
AT ericksond automatedcontrolledreleasedeviceforintravaginalhormonedelivery
AT giordanojo automatedcontrolledreleasedeviceforintravaginalhormonedelivery